Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 30 (4), 983-991
- https://doi.org/10.1016/s0735-1097(97)00253-2
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Losartan in Heart FailureCirculation, 1995
- Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular DysfunctionJAMA, 1993
- Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.Circulation, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Pharmacology of Nonpeptide Angiotensin II Receptor AntagonistsAnnual Review of Pharmacology and Toxicology, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failureThe American Journal of Cardiology, 1991
- Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failureThe American Journal of Cardiology, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987